Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roivant
Pharma
With Dermavant's Vtama struggling, Leerink slashes projections
Sales figures show that Dermavant's Vtama is struggling to catch on. As a result, Leerink has slashed its sales projections for the topical treatment.
Kevin Dunleavy
Nov 14, 2023 11:13am
What does Vivek Ramaswamy say for the life sciences brand?
Aug 15, 2023 10:30am
Arbutus, Genevant claim Pfizer patent infringement in new suit
Apr 4, 2023 11:48am
Moderna's motion to dismiss patent suit denied by federal judge
Nov 3, 2022 4:23pm
Moderna faces a patent infringement suit tied to its COVID shot
Feb 28, 2022 9:55am
Dermavant faces a perfect storm of pressures for tapinarof
Feb 15, 2022 7:10am
